Page last updated: 2024-10-30

letrozole and Basal Ganglia Diseases

letrozole has been researched along with Basal Ganglia Diseases in 1 studies

Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.

Research Excerpts

ExcerptRelevanceReference
"Mrs A, a 68-year-old woman with paranoid schizophrenia, was on long-term psychiatric treatment with long-acting intramuscular zuclopenthixol, quetiapine and alprazolam when, in April 2012, she was diagnosed with right breast infiltrating ductal carcinoma."3.81Possible interaction between letrozole and long-acting injectable zuclopenthixol. ( Aguirre, C; Albeniz, JM; Echaburu, SD; García, MG; Hernandez, R; Lertxundi, U; Ruiz, B, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lertxundi, U1
Hernandez, R1
Albeniz, JM1
Echaburu, SD1
Ruiz, B1
García, MG1
Aguirre, C1

Other Studies

1 other study available for letrozole and Basal Ganglia Diseases

ArticleYear
Possible interaction between letrozole and long-acting injectable zuclopenthixol.
    Nordic journal of psychiatry, 2015, Volume: 69, Issue:1

    Topics: Aged; Antineoplastic Agents; Antipsychotic Agents; Basal Ganglia Diseases; Clopenthixol; Dibenzothia

2015